Clinical Trial of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Oxygen in Women Having Planned Caesarean Delivery (THRIVEN90)

SABA AL-SULTTAN

Status: Completed

Conditions: Pre-oxygenation in Term Pregnant Women

Treatments: Device: THRIVE pre-oxygenation

Study type: Observational

Funder types: Other

Identifiers

NCT04229745

18/0042

Details and patient eligibility

About

Clinical Trial of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) Oxygen in Women having Planned Caesarean Delivery. Cohort study investigating the efficacy of THRIVE pre-oxygenation using pre-determined number of vital capacity breaths and comparing the efficacy to face mask pre-oxygenation. Aimed to recruit ASA 1-2 term pregnant women having elective caesarean section.

Enrollment: 20 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• scheduled to undergo elective caesarean delivery
• singleton pregnancy
• American Society of Anaesthesiologists (ASA) Physical Status Grade II
• gestational age between 37 - 42 weeks

Exclusion criteria

• multiple pregnancy
• pre-eclampsia
• known fetal abnormality
• maternal cardio-respiratory comorbidity
• Body Mass Index (BMI) > 35 kg/m2.